Zeus Trial

We are currently recruiting for the ZEUS trial. If you are eligible, you will receive a text from us, asking if you are interested in taking part.

What is the ZEUS Trial?

ZEUS is a global clinical study investigating if a new medication reduces the risk of having cardiovascular events, (such as a heart attacks and strokes), in people with Cardiovascular Disease, Chronic Kidney Disease, and inflammation. The trial is being run by Novo Nordisk.

Who can participate?

You will eligible to participate in this study if you meet all of the below:
• Aged 18 or over
• Have had a stroke or heart attack, or have insufficient blood flow in your legs
• Have kidney disease which does not require dialysis or a transplant
• Are able to attend regular clinic visits and receive phone calls over a period of up to 4 years.

What will be required if you participate?

You will go through a screening process to ensure you meet the criteria. If you do, the study Doctor will explain exactly what is expected of participants so you can make an informed decision. Your consent to participate, should you decide to join the trial will be taken and recorded. You will then receive the new medication, or a placebo, (a “dummy” which contains no medication which is given for comparison), once a month. You will then attend regular clinic visits with a study Doctor for up to 4 years, as well as receiving support, health, and lifestyle advice from the study staff.

How can I enrol?

If you would like to participate, please sign-up via the link in the text message you have received from us.